Abstract:Although hepatitis B and/or hepatitis C virus were recognized as major risk factor for the development of hepatocellular carcinoma (HCC), certain occupational, environmental, and lifestyle factors also play key roles in HCC tumorigenesis. Moreover, in molecular signaling route, extracellular signal‐regulated kinase (ERK)/nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) signaling was found to be overexpressed and linked to poor prognosis in HCC. Thus, to identify possible nature compound that can suppress ERK/NF‐κB may be benefit to HCC patient. Magnolol, a natural compound derived from herbal plant Magnolia officinalis, has been recognized as a liver protection and antitumor reagent. However, whether magnolol‐inhibited HCC progression correlates with disruption of ERK/NF‐κB signaling is remained unclear. In this studies, we performed SK‐Hep1/luc2 HCC bearing animal model to investigate the anticancer efficacy and mechanism of magnolol on tumor progression. Tumor size and tumor growth rate were dramatically suppressed after treatment of magnolol. In addition, expression of phospho‐ERK (p‐ERK), NF‐κB p65 (Ser536), and tumor progression‐associated proteins, such as matrix metallopeptidase 9 (MMP‐9), vascular endothelial growth factor (VEGF), X‐linked inhibitor of apoptosis protein (XIAP), and CyclinD1 were all significantly decreased by magnolol. Most important, major extrinsic and intrinsic apoptosis signaling factors, including active caspase‐8 and caspase‐9 were both enhanced by magnolol. This study indicated that apoptosis induction through extrinsic/intrinsic pathways and blockage of ERK/NF‐κB activation were associated with magnolol‐inhibited tumor progression in HCC in vivo.

Induction of Apoptosis by Magnolol Via the Mitochondrial Pathway and Cell Cycle Arrest in Renal Carcinoma Cells.

Magnolol Exerts Anticancer Activity in Hepatocellular Carcinoma Cells Through Regulating Endoplasmic Reticulum Stress-Mediated Apoptotic Signaling

Honokiol Induces Apoptosis and Autophagy Via the ROS/ERK1/2 Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo.

Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy

Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells

Apoptosis Induction and ERK/NF‐κB Inactivation Are Associated with Magnolol‐inhibited Tumor Progression in Hepatocellular Carcinoma in Vivo

The Natural Compound Magnolol Inhibits Invasion and Exhibits Potential in Human Breast Cancer Therapy

Effect of Magnetic Nanoparticles on Apoptosis and Cell Cycle Induced by Wogonin in Raji Cells

Magnolol Suppresses Pancreatic Cancer Development in Vivo and in Vitro Via Negatively Regulating TGF-β/Smad Signaling

Magnolol Induces Apoptosis and Suppresses Immune Evasion in Non-small Cell Lung Cancer Xenograft Models

Induction of Apoptosis, Inhibition of MCL-1, and VEGF-A Expression Are Associated with the Anti-Cancer Efficacy of Magnolol Combined with Regorafenib in Hepatocellular Carcinoma

Magnolol Suppresses the Proliferation and Invasion of Cholangiocarcinoma Cells Via Inhibiting the NF-κB Signaling Pathway.

Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells

Targeting Mitophagy to Promote Apoptosis is a Potential Therapeutic Strategy for Cancer

Magnolol Promotes the Autophagy of Esophageal Carcinoma Cells by Upregulating HACE1 Gene Expression.

Magnolol Inhibits Growth of Gallbladder Cancer Cells Through the P53 Pathway

Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells.

Magnolol Protects Against Oxidative Stress-Mediated Neural Cell Damage by Modulating Mitochondrial Dysfunction and PI3K/Akt Signaling

Magnetic Nanoparticle Of Fe3o4 And 5-Bromotetrandrin Interact Synergistically To Induce Apoptosis By Daunorubicin In Leukemia Cells

Magnolol's Therapeutic Efficacy and Immunomodulatory Effects in Oral Squamous Cell Carcinoma

Semi-Synthesis and In Vitro Anti-Cancer Evaluation of Magnolol Derivatives